Thrivent Financial For Lutherans Regeneron Pharmaceuticals, Inc. Transaction History
Thrivent Financial For Lutherans
- $28.6 Billion
- Q1 2025
A detailed history of Thrivent Financial For Lutherans transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 45,672 shares of REGN stock, worth $26.3 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
45,672
Previous 125,194
63.52%
Holding current value
$26.3 Million
Previous $89.2 Million
67.52%
% of portfolio
0.1%
Previous 0.17%
Shares
30 transactions
Others Institutions Holding REGN
# of Institutions
1,476Shares Held
84.8MCall Options Held
1.15MPut Options Held
1.45M-
Vanguard Group Inc Valley Forge, PA9.41MShares$5.42 Billion0.11% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$4.86 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY5.66MShares$3.26 Billion0.28% of portfolio
-
State Street Corp Boston, MA4.79MShares$2.76 Billion0.13% of portfolio
-
Capital International Investors Los Angeles, CA3.99MShares$2.3 Billion0.52% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $61.7B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...